Dr. Neal Mauldin is a triple-board certified veterinarian in the specialty areas of internal medicine, oncology, and radiation oncology. He has been PetCure Oncology’s chief medical officer since 2014. In that role, Dr. Mauldin provides clinical oversight, remote treatment planning and review, and oversees clinical research across PetCure Oncology’s national network. He is also responsible for leadership of PetCure’s Scientific Advisory Board, an independent group of human and veterinary clinicians with expertise in radiation oncology, medical oncology, stereotactic radiation, and medical physics.
After achieving board certification in internal medicine in 1988 and medical oncology in 1989, Dr. Mauldin added radiation oncology in 1994 - the first year that board certification was offered in that field. More than two decades later, he has become known as one of the leading experts in radiation therapy for pets and a pioneer in the integration of stereotactic radiation (SRS/SRT) into veterinary medicine. Dr. Mauldin has treated more than 2,000 pets with SRS/SRT since 2010.
His professional experience includes 11 years at the Donaldson-Atwood Cancer Clinic of the Animal Medical Center in New York, eight years of clinical and educational work at Louisiana State University, and 10 years at Western Veterinary Specialist and Emergency Centre in Calgary, Alberta.
Dr. Mauldin has authored over 20 peer-reviewed publications and numerous textbook chapters pertaining to the specialty of veterinary oncology. He has presented invited scientific abstracts at over 40 national and international meetings, served on the residency training and examination committees for the specialties of medical and radiation oncology, and is a past president of the Veterinary Cancer Society.